Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
Recruiting
N/A
Interventional Study
Diabetic Retinopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 922 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the interpretation of fundus photographs obtained by trained nursing assistant using a portable fundus camera in a primary care setting, compared with images obtained by the same method, but interpreted by ophthalmologists.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults (\> 18 years old) diagnosed with diabetes mellitus who agree to participate in the study.
Exclusion Criteria:
* Any contraindication for pharmacological mydriasis (such as knowledge of having closed-angle glaucoma, pregnancy).
* Life expectancy less than 6 months
Contacts